118 related articles for article (PubMed ID: 38277165)
41. TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop.
Yang Y; Wang Z; Yang H; Wang L; Gillespie SR; Wolosin JM; Bernstein AM; Reinach PS
PLoS One; 2013; 8(10):e77300. PubMed ID: 24098582
[TBL] [Abstract][Full Text] [Related]
42. In vivo and in vitro demonstration of epithelial cell-induced myofibroblast differentiation of keratocytes and an inhibitory effect by amniotic membrane.
Choi TH; Tseng SC
Cornea; 2001 Mar; 20(2):197-204. PubMed ID: 11248830
[TBL] [Abstract][Full Text] [Related]
43. Corneal integrity after refractive surgery. Effects of radial keratotomy and mini-radial keratotomy.
Pinheiro MN; Bryant MR; Tayyanipour R; Nassaralla BA; Wee WR; McDonnell PJ
Ophthalmology; 1995 Feb; 102(2):297-301. PubMed ID: 7862417
[TBL] [Abstract][Full Text] [Related]
44. Corneal wound healing after ultraviolet-A/riboflavin collagen cross-linking: a rabbit study.
Salomão MQ; Chaurasia SS; Sinha-Roy A; Ambrósio R; Esposito A; Sepulveda R; Agrawal V; Wilson SE
J Refract Surg; 2011 Jun; 27(6):401-7. PubMed ID: 21162471
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization.
Sonoda K; Sakamoto T; Yoshikawa H; Ashizuka S; Ohshima Y; Kishihara K; Nomoto K; Ishibashi T; Inomata H
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2245-51. PubMed ID: 9804132
[TBL] [Abstract][Full Text] [Related]
46. Nidogen-2: Location and expression during corneal wound healing.
Gallego-Muñoz P; Lorenzo-Martín E; Fernández I; Herrero-Pérez C; Martínez-García MC
Exp Eye Res; 2019 Jan; 178():1-9. PubMed ID: 30243864
[TBL] [Abstract][Full Text] [Related]
47. Localization of thrombospondin-1 and myofibroblasts during corneal wound repair.
Matsuba M; Hutcheon AE; Zieske JD
Exp Eye Res; 2011 Oct; 93(4):534-40. PubMed ID: 21749870
[TBL] [Abstract][Full Text] [Related]
48. Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
Pereira-Souza AL; Ambrósio R; Bandeira F; Salomão MQ; Souza Lima A; Wilson SE
J Refract Surg; 2022 Nov; 38(11):741-746. PubMed ID: 36367262
[TBL] [Abstract][Full Text] [Related]
49. Corneal stroma PDGF blockade and myofibroblast development.
Kaur H; Chaurasia SS; de Medeiros FW; Agrawal V; Salomao MQ; Singh N; Ambati BK; Wilson SE
Exp Eye Res; 2009 May; 88(5):960-5. PubMed ID: 19133260
[TBL] [Abstract][Full Text] [Related]
50. A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.
Yamamoto M; Quantock AJ; Young RD; Okumura N; Ueno M; Sakamoto Y; Kinoshita S; Koizumi N
Mol Vis; 2012; 18():1727-39. PubMed ID: 22815626
[TBL] [Abstract][Full Text] [Related]
51. Standardization of corneal alkali burn methodology in rabbits.
Villabona-Martinez V; Sampaio LP; Shiju TM; Wilson SE
Exp Eye Res; 2023 May; 230():109443. PubMed ID: 36948438
[TBL] [Abstract][Full Text] [Related]
52. Basement membrane regeneration and TGF-β1 expression in rabbits with corneal perforating injury.
Meng N; Wu J; Chen J; Luo Y; Xu L; Li X
Mol Vis; 2023; 29():58-67. PubMed ID: 37287643
[TBL] [Abstract][Full Text] [Related]
53. IL-1 and TGF-β Modulation of Epithelial Basement Membrane Components Perlecan and Nidogen Production by Corneal Stromal Cells.
Saikia P; Thangavadivel S; Medeiros CS; Lassance L; de Oliveira RC; Wilson SE
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5589-5598. PubMed ID: 30480706
[TBL] [Abstract][Full Text] [Related]
54. Angiotensin II Type I Receptor Blockade Is Associated with Decreased Cutaneous Scar Formation in a Rat Model.
Murphy A; LeVatte T; Boudreau C; Midgen C; Gratzer P; Marshall J; Bezuhly M
Plast Reconstr Surg; 2019 Nov; 144(5):803e-813e. PubMed ID: 31385893
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation.
Folger PA; Zekaria D; Grotendorst G; Masur SK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2534-41. PubMed ID: 11581194
[TBL] [Abstract][Full Text] [Related]
56. Impact of topical anti-fibrotics on corneal nerve regeneration in vivo.
Hindman HB; DeMagistris M; Callan C; McDaniel T; Bubel T; Huxlin KR
Exp Eye Res; 2019 Apr; 181():49-60. PubMed ID: 30660507
[TBL] [Abstract][Full Text] [Related]
57. Trichostatin a inhibits corneal haze in vitro and in vivo.
Sharma A; Mehan MM; Sinha S; Cowden JW; Mohan RR
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2695-701. PubMed ID: 19168895
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-1 receptor role in the viability of corneal myofibroblasts.
Barbosa FL; Lin M; Santhiago MR; Singh V; Agrawal V; Wilson SE
Exp Eye Res; 2012 Mar; 96(1):65-9. PubMed ID: 22251454
[TBL] [Abstract][Full Text] [Related]
59. Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.
Gupta S; Fink MK; Kempuraj D; Sinha NR; Martin LM; Keele LM; Sinha PR; Giuliano EA; Hesemann NP; Raikwar SP; Chaurasia SS; Mohan RR
Mol Ther; 2022 Oct; 30(10):3257-3269. PubMed ID: 35780298
[TBL] [Abstract][Full Text] [Related]
60. The Cornea: No Difference in the Wound Healing Response to Injury Related to Whether, or Not, There's a Bowman's Layer.
Wilson SE
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
